Third, as mentioned above, we did not measure the CSF orexin levels of the participants; therefore, it is possible that some HLA-positive patients diagnosed with NT2 may turn out to be NT1 without cataplexy or NT2 with intermediately lowered CSF orexin levels if CSF orexin were measured. The gene discussed is HCRT; the disease is Cataplexy.